Related Experiment Video
Updated: Apr 7, 2026

09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.9K
[The atypical developments of rolandic epilepsy are predictable complications]
Gabriela Pesántez-Ríos1, Antonio Martínez-Bermejo, Joaquín Arcas
1UAM. Universidad Autonoma de Madrid. Hospital Universitario La Paz, 28046 Madrid, Espana.
Revista De Neurologia
|July 17, 2015
Summary
Rolandic epilepsy developing atypically presents with early onset, increased seizure frequency, and specific EEG patterns. These electroclinical features indicate a spectrum of neurological conditions requiring further investigation.
Area of Science:
- Pediatric Neurology
- Epileptology
- Clinical Neurophysiology
Context:
- Rolandic epilepsy (RE) exhibits variable phenotypes, influenced by age and genetics.
- Atypical features in RE suggest a spectrum of underlying conditions.
- Understanding these atypical presentations is crucial for diagnosis and management.
Purpose:
- To investigate the electroclinical characteristics associated with atypical development in rolandic epilepsy.
- To identify specific EEG and clinical markers indicative of atypical RE phenotypes.
Summary:
- A retrospective study analyzed nine children with rolandic epilepsy exhibiting atypical features and electrical status epilepticus during sleep (ESES).
- Patients presented with early onset (average 5 years), clinical and EEG deterioration, and frontocentrotemporal EEG foci.
- Atypical benign focal epilepsy (ABFE) and continuous spike-wave during sleep (CSWS) were observed, alongside cognitive and behavioral deficits.
Impact:
- Identifies key electroclinical features for diagnosing atypical rolandic epilepsy.
- Highlights the association between ESES and atypical RE phenotypes.
- Emphasizes the need for early recognition of atypical RE to address associated learning and behavioral issues.
Related Concept Videos
Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification
2.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K

